Literature DB >> 1671712

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.

A Goate1, M C Chartier-Harlin, M Mullan, J Brown, F Crawford, L Fidani, L Giuffra, A Haynes, N Irving, L James.   

Abstract

A locus segregating with familial Alzheimer's disease (AD) has been mapped to chromosome 21, close to the amyloid precursor protein (APP) gene. Recombinants between the APP gene and the AD locus have been reported which seemed to exclude it as the site of the mutation causing familial AD. But recent genetic analysis of a large number of AD families has demonstrated that the disease is heterogeneous. Families with late-onset AD do not show linkage to chromosome 21 markers. Some families with early-onset AD show linkage to chromosome 21 markers, but some do not. This has led to the suggestion that there is non-allelic genetic heterogeneity even within early onset familial AD. To avoid the problems that heterogeneity poses for genetic analysis, we have examined the cosegregation of AD and markers along the long arm of chromosome 21 in a single family with AD confirmed by autopsy. Here we demonstrate that in this kindred, which shows linkage to chromosome 21 markers, there is a point mutation in the APP gene. This mutation causes an amino-acid substitution (Val----Ile) close to the carboxy terminus of the beta-amyloid peptide. Screening other cases of familial AD revealed a second unrelated family in which this variant occurs. This suggests that some cases of AD could be caused by mutations in the APP gene.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1671712     DOI: 10.1038/349704a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  1053 in total

Review 1.  Modulation of amyloid beta protein precursor processing as a means of retarding progression of Alzheimer's disease.

Authors:  S L Wagner; B Munoz
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

Review 2.  Genetic insights into schizophrenia.

Authors:  A S Bassett; E W Chow; D M Waterworth; L Brzustowicz
Journal:  Can J Psychiatry       Date:  2001-03       Impact factor: 4.356

Review 3.  Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.

Authors:  M Goedert
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

4.  The tangled biology of tau.

Authors:  K C Wilhelmsen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 5.  A genetic dichotomy model for the inheritance of Alzheimer's disease and common age-related disorders.

Authors:  R E Tanzi
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

Review 6.  Genetic risk factors in Alzheimer's disease.

Authors:  L Tilley; K Morgan; N Kalsheker
Journal:  Mol Pathol       Date:  1998-12

7.  The angiotensin-converting enzyme gene as a possible risk or protective factor in Alzheimer's disease.

Authors:  T V Shcherbatykh; S A Kiryanov; G I Korovaitseva; N D Selezneva; N I Voskresenskaya; V E Golimbet; L Farrer; S I Gavrilova; E I Rogaev
Journal:  Neurosci Behav Physiol       Date:  2001 Mar-Apr

8.  Late Simian virus 40 transcription factor is a target of the phosphoinositide 3-kinase/Akt pathway in anti-apoptotic Alzheimer's amyloid precursor protein signalling.

Authors:  Tarek Kashour; Teralee Burton; Alexander Dibrov; Francis M Amara
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

Review 9.  It's all about tau.

Authors:  Cheril Tapia-Rojas; Fabian Cabezas-Opazo; Carol A Deaton; Erick H Vergara; Gail V W Johnson; Rodrigo A Quintanilla
Journal:  Prog Neurobiol       Date:  2018-12-31       Impact factor: 11.685

Review 10.  The solved and unsolved mysteries of the genetics of early-onset Alzheimer's disease.

Authors:  Ekaterina Rogaeva
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.